1Eellenbogen KA,Dias VC,cardello FP,et al.Safety and efficacy of intravenous,diltiazem in atrial fibrillation or atrial flutter.Am J Cardiol,1995,75:45-49.
5Aronow WS. Etiology, pathophysiology, and treatment of atrial fibrillation: part 1 [J]. Cardiol Rev, 2008, 16(4): 181-188.
6Olshansky B, Rosenfeld LE, Warner AL, et al. The atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study: approaches to control rate in atrial fibrillation[J]. J Am Coll Cardiol, 2004, 43(7): 1201-1208.
7Berisso MZ, Fabbri G, Gonzini L, et al. Antiarrhythmic strategies in patients with atrial fibrillation managed by cardiologists and internists: Antithrombotic Agents in Atrial Fibrillation (ATA-AF) survey[J]. J Cardiovasc Med (Hagerstown), 2014, 15(8): 626-635.
8Lip GY, Da LE. Stroke prevention in atrial fibrillation: a systematic review[J]. JAMA, 2015, 313(19): 1950-1962.
9January CT, Wann LS, Alpert JS, et al. College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[J]. J Am Coll Cardiol, 2014, 64(21): e1-e76.
10Rogenstein C, Kelly AM, Mason S, et al. An international view of how recent-onset atrial fibrillation is treated in the emergency department[J]. Acad Emerg Med, 2012, 19(11): 1255-1260.
